Regulatory clarity urged for CME’s single-stock futures

What happened: CME's single-stock futures may need clearer regulatory treatment to gain wider traction, as a dual-oversight framework brings securities-based market access and short-selling rules that do not easily fit the futures construct. Key numbers: CME launched more than 70 SSFs in July, on names including Apple, Nvidia and SpaceX, reviving the product after a six-year hiatus. Why it matters: The mismatch between securities rules and the futures construct is presented as a barrier to the contracts gaining wider adoption.

CME's single-stock futures may need clearer regulatory treatment to gain wider traction, as a dual-oversight framework brings securities-based market access and short-selling rules that do not easily fit the futures construct.

The mismatch between securities rules and the futures construct is presented as a barrier to the contracts gaining wider adoption.